Evolution of the Average Target: Medical Properties Trust, Inc.

Evolution of the Target Price: Medical Properties Trust, Inc.

Changes in Analyst Recommendations: Medical Properties Trust, Inc.

a2.QYMc4jjrWoNnuqp2UQ2I0FExXvNRUWOSX2v0WyjQEkY.FNN_oHa5O7oQ2_hCAX3vgTJiLp0lGxKgGji4OGW9Kih10HCmaN4_tSj93Q~69942aaa7eb4707e4488f4d43e40995a
08-17 BofA Securities Adjusts Medical Properties Trust Price Target to $4.25 From $5 MT
06-18 RBC Cuts Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
03-02 RBC Raises Price Target on Medical Properties Trust to $5 From $4.50, Keeps Sector Perform, Speculative Risk MT
25-06-30 RBC Lowers Price Target on Medical Properties Trust to $4.50 From $5, Keeps Sector Perform, Speculative Risk MT
25-03-12 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Raises Price Target to $9 From $5 MT
25-03-10 RBC Raises Price Target on Medical Properties Trust to $5 From $4, Keeps Sector Perform, Speculative Risk MT
24-09-13 Colliers Upgrades Medical Properties Trust to Buy From Neutral, Price Target is $6.50 MT
24-09-12 Truist Securities Raises Price Target on Medical Properties Trust to $6 From $5, Maintains Hold Rating MT
24-07-02 BNP Paribas Exane Downgrades Medical Properties Trust to Neutral From Outperform, Adjusts Price Target to $4 From $6 MT
24-05-30 Truist Adjusts Price Target on Medical Properties Trust to $5 From $4.50, Maintains Hold Rating MT
24-05-14 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 Amid Tenant-Related Concerns MT
24-05-14 RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 MT
24-04-17 Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2 MT
24-04-08 Truist Securities Raises Price Target on Medical Properties Trust to $4.50 From $4, Maintains Hold Rating MT
24-03-01 BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Price Target is $6 MT
24-02-20 RBC Cuts Price Target on Medical Properties Trust to $5 From $8 on Steward-Related Rent Disruption, Keeps Outperform, Speculative Risk MT
24-01-05 KeyBanc Downgrades Medical Properties Trust to Sector Weight From Overweight, Removes $15 Price Target Amid Uncertainty, Risks to Tenant Health MT
24-01-03 Mizuho Securities Adjusts Medical Properties Trust's Price Target to $7 From $9, Keeps Neutral Rating MT
23-11-28 RBC Cuts Price Target on Medical Properties Trust to $8 From $10, Keeps Outperform Rating MT
23-11-10 Stifel Downgrades Medical Properties Trust to Hold From Buy, Adjusts Price Target to $4.50 From $12 MT
23-10-16 Wells Fargo Downgrades Medical Properties Trust to Underweight From Equalweight, Cuts Price Target to $4 From $7 MT
23-08-31 Mizuho Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $9 From $18 MT
23-08-22 Barclays Adjusts Price Target on Medical Properties Trust to $10 From $12, Maintains Overweight Rating MT
23-08-21 JPMorgan Downgrades Medical Properties Trust to Underweight From Neutral, Adjusts Price Target to $7 From $9 MT
23-08-21 Analyst recommendations: Alphabet, AstraZeneca, FMC Corp, Target, Wise... Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+50.74%
+14.57%
+17.5%
+11.21%
+13.13%
+23.49%
+20.28%
+26.22%
+17.29%
+15.43%
Average +20.99%
Weighted average by Cap. +15.97%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.650USD
Average target price
5.125USD
Spread / Average Target
+40.41%
High Price Target
7.000USD
Spread / Highest target
+91.78%
Low Price Target
4.250USD
Spread / Lowest Target
+16.44%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. MPT Stock
  4. Consensus Medical Properties Trust, Inc.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!